Page 100 - 《中国药房》2023年14期

[19] BASU A，CHADDA R K，SOOD M，et al. Association of al. BDNF val66met polymorphism，white matter abnor‐
serotonin transporter（SLC6A4）and receptor（5HTR1A， malities and remission of geriatric depression[J]. J Affect
5HTR2A）polymorphisms with response to treatment with Disord，2010，125（1/2/3）：262-268.
escitalopram in patients with major depressive disorder：a [31] CHANG H S，LEE H Y，HAM B J，et al. Association be‐
preliminary study[J]. Indian J Med Res，2015，142（1）： tween brain-derived neurotrophic factor V66M and treat‐
40-45. ment responses to escitalopram in patients with major de‐
[20] GARFIELD L D，DIXON D，NOWOTNY P，et al. Com‐ pressive disorder[J]. Asia Pac Psychiatry，2012，4（4）：
mon selective serotonin reuptake inhibitor side effects in 241-249.
older adults associated with genetic polymorphisms in the [32] ZOBEL A，SCHUHMACHER A，JESSEN F，et al. DNA
serotonin transporter and receptors：data from a rando- sequence variants of the FKBP5 gene are associated with
mized controlled trial[J]. Am J Geriatr Psychiatry，2014， unipolar depression[J]. Int J Neuropsychopharmacol，
22（10）：971-979. 2010，13（5）：649-660.
[21] 安治国 . 新疆维吾尔族抑郁症 CYP2C19 基因多态性及 [33] LEKMAN M，LAJE G，CHARNEY D，et al. The FKBP5-
与艾司西酞普兰疗效的关系[D].乌鲁木齐：新疆医科大 gene in depression and treatment response：an association
学，2011. study in the sequenced treatment alternatives to relieve de‐
[22] JIN Y Y，POLLOCK B G，FRANK E，et al. Effect of age， pression（STAR*D）cohort[J]. Biol Psychiatry，2008，63
weight，and CYP2C19 genotype on escitalopram exposure （12）：1103-1110.
[J]. J Clin Pharmacol，2010，50（1）：62-72. [34] SCHATZBERG A F，DEBATTISTA C，LAZZERONI L
[23] UCKUN Z，BASKAK B，OZEL-KIZIL E T，et al. The im‐ C，et al. ABCB1 genetic effects on antidepressant out‐
pact of CYP2C19 polymorphisms on citalopram metabo‐ comes：a report from the iSPOT-D trial[J]. Am J Psychia‐
lism in patients with major depressive disorder[J]. J Clin try，2015，172（8）：751-759.
Pharm Ther，2015，40（6）：672-679. [35] LEE S H，LEE M S，LEE J H，et al. MRP1 polymor‐
[24] 何欠欠 . CYP2C19 酶多型性与艾司西酞普兰治疗惊恐 phisms associated with citalopram response in patients
障碍临床疗效间的关联研究[D]. 天津：天津医科大学， with major depression[J]. J Clin Psychopharmacol，2010，
2017. 30（2）：116-125.
[25] HUEZO-DIAZ P，PERROUD N，SPENCER E P，et al. [36] ARIAS B，SERRETTI A，MANDELLI L，et al. Dysbindin
CYP2C19 genotype predicts steady state escitalopram gene（DTNBP1）in major depression：association with
concentration in GENDEP[J]. J Psychopharmacol，2012， clinical response to selective serotonin reuptake inhibitors
26（3）：398-407. [J]. Pharmacogenet Genomics，2009，19（2）：121-128.
[26] HODGSON K，TANSEY K E，UHER R，et al. Exploring [37] HE Q Q，SHEN Z X，REN L，et al. The association of
the role of drug-metabolising enzymes in antidepressant catechol-O-methyltransferase（COMT）rs4680 polymor‐
side effects[J]. Psychopharmacology（Berl），2015，232 phisms and generalized anxiety disorder in the Chinese
（14）：2609-2617. Han population[J]. Int J Clin Exp Pathol，2020，13（7）：
[27] KUO H W，LIU S C，TSOU H H，et al. CYP1A2 genetic 1712-1719.
polymorphisms are associated with early antidepressant [38] HE Q Q，SHEN Z X，REN L，et al. Association of NPSR1
escitalopram metabolism and adverse reactions[J]. Phar‐ rs324981 polymorphism and treatment response to antide‐
macogenomics，2013，14（10）：1191-1201. pressants in Chinese Han population with generalized
[28] 宋喜，孙宁，刘莎，等. 脑源性神经营养因子基因多态性 anxiety disorder[J]. Biochem Biophys Res Commun，
与西酞普兰临床疗效的关联性[J]. 中国医疗前沿，2011， 2018，504（1）：137-142.
6（2）：20-22. [39] HICKS J K，SWEN J J，THORN C F，et al. Clinical phar‐
[29] ZENG D，HE S，LI J Y，et al. Brain-derived neurotrophic macogenetics implementation consortium guideline for
factors Val66Met and C270T polymorphisms influence CYP2D6 and CYP2C19 genotypes and dosing of tricyclic
citalopram/escitalopram response in Chinese patients with antidepressants[J]. Clin Pharmacol Ther，2013，93（5）：
major depressive disorder[J]. Pharmaceutical-sciences， 402-408.
2019，81（4）：690-698. （收稿日期：2023-01-15 修回日期：2023-06-28）
[30] ALEXOPOULOS G S，GLATT C E，HOPTMAN M J，et （编辑：陈 宏）

· 1754 · China Pharmacy 2023 Vol. 34 No. 14 中国药房 2023年第34卷第14期